Stock Earnings

Question 1

How did IKT's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Inhibikase Therapeutics Inc is $-0.13, not beating expectations of $-0.13.

Question 2

How did Inhibikase Therapeutics Inc IKT's revenue perform in the last quarter?

Accepted Answer

Inhibikase Therapeutics Inc revenue for the last quarter is $-0.13

Question 3

What is the revenue estimate for Inhibikase Therapeutics Inc?

Accepted Answer

According to 5 of Wall street analyst, the revenue estimate of Inhibikase Therapeutics Inc range from $0.0 to $0.0

Question 4

What's the earning quality score for Inhibikase Therapeutics Inc?

Accepted Answer

Inhibikase Therapeutics Inc has a earning quality score of B+/52.23486. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Inhibikase Therapeutics Inc report earnings?

Accepted Answer

Inhibikase Therapeutics Inc next earnings report is expected in 2026-02-12

Question 6

What are Inhibikase Therapeutics Inc's expected earnings?

Accepted Answer

Inhibikase Therapeutics Inc expected earnings is $0.0, according to wall-street analysts.

Question 7

Did Inhibikase Therapeutics Inc beat earnings expectations?

Accepted Answer

Inhibikase Therapeutics Inc recent earnings of $0.0 does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-0.13	$-0.13	--	--
Q2 '25	$-0.09	$-0.11	+22.22%	BEAT
Q1 '25	$-0.1	$-0.17	+70.0%	BEAT
Q4 '24	$-0.08	$-0.5	+525.0%	BEAT
Q3 '24	$-0.37	$-0.65	+75.67%	BEAT

Inhibikase Therapeutics Inc (IKT) Price

IKT Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ